摘要
简述上市后药品风险管理的目的和风险来源,并通过查阅文献资料,介绍了美国上市后药品风险管理体系,旨在借鉴先进经验以加强和完善我国药品风险管理体系。
This text briefly introduces the objective of post-market risk management and the source of medical product risks, adopts literature research method, and researches on FDA post-market risk management of medical product in order to offer some apocalypse about the drugs risk management for our country.
出处
《中国药物警戒》
2007年第6期374-376,共3页
Chinese Journal of Pharmacovigilance
